Bimekizumab offers fresh option for patients with chronic conditions More: HSE approves new treatment for hidradenitis suppurativa and axial spondyloarthritis Source: News
read more
hVIVO celebrates landmark deal highlighting its role in advancing influenza therapy More: MSD to acquire Cidara after positive phase 2b trial results Source: News
read more
eXmoor Pharma and Royal Free London NHS Foundation Trust have announced a strategic collaboration to create a seamless pathway for cell and gene therapy development and manufacturing in the UK. The partnership, unveiled on 26 November in Bristol and London,
read more
Foundation’s test to be used in Oxford-led blood biomarker trial More: Alzheimer’s prevention charity pioneers research on nutrition biomarkers to detect risk Source: News
read moreFrench vaccine maker Valneva is closing down a site that houses both operational and R&D work, impacting 30 employee roles. More: Vaccine-focused Valneva consolidates R&D footprint by shuttering site, eliminating 30 roles Source: fierce
read moreThe U.S. has revealed price reductions for the second round of prescription drugs negotiated by Medicare through the Inflation Reduction Act (IRA). Headlining the list of 15 treatments that will undergo price reductions in 2027 are Novo Nordisk’s semaglutide products,
read more© 1994 - 2026 B.M. Pharmaceuticals